Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
about
Cancer- and cancer treatment-associated cognitive change: an update on the state of the scienceOpening up the window into "chemobrain": a neuroimaging reviewAltered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionMemory and cancer: a review of the literatureStatus of adjuvant endocrine therapy for breast cancer.Regional brain activation during verbal declarative memory in metastatic breast cancerPrevalence, mechanisms, and management of cancer-related cognitive impairment.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.An update on cancer- and chemotherapy-related cognitive dysfunction: current status.A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.Assessing cognitive function in adults during or following chemotherapy: a scoping review.Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Topological Organization of Metabolic Brain Networks in Pre-Chemotherapy Cancer with Depression: A Resting-State PET StudyFrontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.Multivariate analysis of brain metabolism reveals chemotherapy effects on prefrontal cerebellar system when related to dorsal attention network.Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.Brain vulnerability to chemotherapy toxicities.Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study.Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.Cognitive dysfunction and cancer: which consequences in terms of disease management?Chemotherapy-related cognitive dysfunction.An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Clearing the air: a review of our current understanding of "chemo fog".Cognitive dysfunction after chemotherapy for breast cancer.Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Management of side effects during and post-treatment in breast cancer survivors.Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer.Intra-individual variability in women with breast cancer.Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.Relationship between fruit and vegetable intake and interference control in breast cancer survivors.Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.Study of the cognitive effects of chemotherapy: considerations in selection of a control group.Locus of control, optimism, and recollections of depression and self-reported cognitive functioning following treatment for colorectal cancer.Late effects of adjuvant chemotherapy for breast cancer on fine motor function.
P2860
Q26853289-104F4B6F-79A3-4D79-BAA4-80FBA6FFF9EEQ30596880-5AC00574-0DE9-4567-A7C2-1E597B1CF583Q33590378-30F98B3E-8489-4D41-B2F8-47C32034787BQ33663544-62A31D12-ED56-45E5-B9FD-99355C60CAC2Q33739138-16021310-4431-4A21-BA59-68C8DA303373Q33810520-600F1A7B-E20C-4C5A-B6C5-E2434C3A75D1Q33854977-5F09B914-3B97-4610-8F61-C8645CEEE729Q34395112-53AFC35F-550D-4C5D-AC35-98943981B314Q35059702-2375B4C0-3C97-464F-A951-860E971CAB28Q35161191-124BF838-723D-44E9-8AC4-0098EF008A95Q35446931-876F5030-EA51-4C34-AA6F-284503574058Q35834672-2BCB6C8B-4DA2-4F19-AFEB-316AB7764C27Q35986398-3F637B1A-8A9B-4F5A-B12C-12BB1783D0C4Q36097701-4E0488D4-6E62-4B7F-9D39-A3984AECF1FDQ36188728-741C3F92-3A49-4296-8339-6039A4DFB69FQ36775693-F531DEEC-14BE-4B3A-9286-D298EB450E19Q36797484-4EEF33DF-5BF9-4B55-B0D6-1AB4CBBE606DQ36867082-CBF2793E-D6EA-4B69-A5A1-66374C8799B8Q37211338-542C3510-A619-4AA9-9D53-1CFC99A7528BQ37366039-719F5C50-D37B-4FEC-AA1F-FF6260CEE5BCQ37585300-AF792F49-F902-4124-AF1C-F82E50D1467CQ37830371-10EA504C-41D7-48DB-BEFD-3A3A35A9E5B9Q37831271-B18F924A-80DB-4D5E-ADAD-E64586054047Q37997653-82EF2DFD-FEBF-4C97-A017-C6FE820BF973Q38000038-48C2C3B2-C104-4A89-B264-16C18D6A6B05Q38088668-09C3CE70-075A-4EA7-A79B-07DB7522584AQ38198215-75624D84-60E4-498F-89C8-8ED09D468082Q38344507-7D899AEC-CCD1-499D-B6E2-5F2E7A6C9EB2Q38551397-A76DEF1A-522D-47AE-B172-217AC25C5ED1Q38636806-2ACF6CAF-1D1C-492B-A2B5-4F877FC85A4FQ38657842-1B78D08D-0B99-4C9E-B763-96D17B689E72Q38779635-84B2FEF3-F478-4645-88D4-C12CB6887F84Q39233062-D3AF79F1-95D6-40C1-B82A-17BFE6A71A48Q39544939-86D23BFD-4856-4AC5-AA5B-9A9C01CB3657Q40783797-53BB67FC-E651-4BEC-94AB-DC3284BCE8AAQ41518631-83EA12BB-39C1-4C21-8F7A-35568C350E27Q45111650-8948E392-9AAA-49DA-87E9-C954A74DA290Q45924447-E47A4957-5B4F-4506-9E7A-294D72B67A63Q47289963-FC320FB5-45AA-4145-A468-030E909DB6B2Q48046482-DC03ADEB-3964-47B6-AD59-E8D9A2339566
P2860
Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cognitive effects of chemother ...... tients 1 year after treatment.
@en
Cognitive effects of chemother ...... tients 1 year after treatment.
@nl
type
label
Cognitive effects of chemother ...... tients 1 year after treatment.
@en
Cognitive effects of chemother ...... tients 1 year after treatment.
@nl
prefLabel
Cognitive effects of chemother ...... tients 1 year after treatment.
@en
Cognitive effects of chemother ...... tients 1 year after treatment.
@nl
P2093
P356
P1433
P1476
Cognitive effects of chemother ...... tients 1 year after treatment.
@en
P2093
Angela Stewart
Barbara Collins
Catherine Bielajew
Joyce Mackenzie
Shailendra Verma
P2860
P304
P356
10.1002/PON.1379
P577
2009-02-01T00:00:00Z